A recent retrospective analysis of 438 patients has identified a potential association between low baseline eosinophil counts and the clinical severity of bronchiectasis, as well as an increased risk of short-term acute exacerbations. The study, conducted to investigate the role of blood cell counts in disease progression, sought to clarify how different levels of eosinophils might correlate with patient outcomes following hospital discharge. By examining the first complete blood count obtained upon admission, researchers categorized participants into three distinct groups based on their eosinophil levels, providing a foundation for evaluating markers of systemic inflammation in this chronic respiratory condition.
The researchers focused their investigation on differences in various laboratory parameters and the frequency of acute exacerbations experienced by these patients within one year after being discharged from the hospital. By utilizing receiver operating characteristic (ROC) curves, the team also performed an exploratory analysis to determine the association between eosinophil levels and the likelihood of future acute exacerbations.
The findings revealed notable differences in the inflammatory profile of patients with the lowest eosinophil counts. In Group A, the study observed significantly elevated levels of several inflammatory markers compared to those in the other two cohorts. Specifically, neutrophil counts, C-reactive protein (CRP), globulin, the systemic inflammatory index (SII), and the neutrophil-to-lymphocyte ratio (NLR) were all found to be significantly higher in the group with the lowest eosinophil counts, with these differences maintaining statistical significance at a P-value of less than 0.05.
Beyond the baseline laboratory parameters, the clinical outcomes for patients in the low eosinophil group appeared distinct. This cohort exhibited a higher incidence of short-term acute exacerbations during the study period. Furthermore, these patients demonstrated a higher frequency of acute exacerbations following their discharge from the hospital compared to those with higher eosinophil counts, suggesting that very low levels of these white blood cells may serve as a potential reference indicator for identifying patients at higher risk for recurrent episodes of illness.
The research team employed univariable Cox regression analysis to evaluate the predictive power of various blood components. While the researchers found that the hazard ratios for platelets, eosinophils, and neutrophils could not be proven to independently predict acute exacerbation in this specific study population, they emphasized that the potential effects of these components on bronchiectasis outcomes cannot be definitively excluded.
An analysis of the ROC curves provided further insight into the potential utility of these markers when considered in combination. Within the subset of patients presenting with low eosinophil counts, the study found that combining eosinophil and neutrophil counts demonstrated a stronger exploratory association for predicting acute exacerbations within the year following discharge compared to the overall study population. This combined preliminary observation yielded an area under the curve (AUC) of 0.781, indicating a meaningful potential for these markers to refine risk assessment in specific patient groups.
The authors conclude that while these findings represent an exploratory stage of research, they underscore a meaningful relationship between low eosinophil counts and the severity and exacerbation frequency of bronchiectasis.
Subject of Research: Association between low eosinophil counts and bronchiectasis severity.
Article Title: Exploratory analysis of associated factors of very low eosinophil counts for acute exacerbation and disease severity of bronchiectasis
Article References: Wei, Y., Wu, M., Jiang, J., Mo, J., & Wang, H. (2026). Exploratory analysis of associated factors of very low eosinophil counts for acute exacerbation and disease severity of bronchiectasis. Frontiers in Medicine, 13, Article 1916927. https://doi.org/10.3389/fmed.2026.1916927
Image Credits: AI Generated
DOI: 10.3389/fmed.2026.1916927
Keywords: Bronchiectasis, Eosinophils, Acute Exacerbation, Retrospective Analysis, Neutrophils, Disease Severity, Inflammation, C-reactive Protein, Systemic Inflammatory Index, Neutrophil-to-Lymphocyte Ratio, Clinical Research, Respiratory Medicine, Biomarkers, Prognostic Factors, Healthcare Outcomes
News Source: Ophelia Keating. (November 17, 2026). Low Eosinophil Counts Linked to Bronchiectasis Exacerbations and Severity. Scienmag.



